TF and breast cancer: Although it is unclear whether this prometastatic effect of TF-FVII complex on tumor cells is caused by its proteolytic activity or its signaling function, practically, TF-inhibitory antibodies or FVII-deficiency reduce metastasis in murine breast cancer models (Versteeg, 2015; Rondon et al., 2019).